Australia Launches New Cochlear Implant Guidelines
Australia has released new national guidelines intended to expand access to cochlear implants by reducing wait times and broadening eligibility. The initiative emphasizes early intervention and integration with community support. The move aligns with a broader push for representation in audiology, with practitioners like Dr. Stacey Lim sharing their lived experience to build patient trust and reduce stigma around hearing aids and implants.
- An estimated 1 in 6 Australians currently has hearing loss, a figure projected to rise to 1 in 4 by 2050. However, only about 10% of adults who could benefit from a cochlear implant have one, a rate that has not improved in 25 years. - The new bi-national guidelines were developed over three years by the ANZ Hearing Health Collaborative (ANZHHC), a group of 70 stakeholders including surgeons, audiologists, and consumer representatives. - The initiative was co-chaired by surgeon Professor Payal Mukherjee, audiologist Dr. Jaime Leigh, and Macquarie University Professor Bamini Gopinath. - Untreated hearing loss costs the Australian economy an estimated $11.75 to $15.9 billion annually in lost productivity and other impacts. - The general price of a cochlear implant device in Australia starts at $25,000, though costs are often covered through public hospitals, private health insurance, or the Department of Veterans' Affairs. - Previously, a common referral indicator for a cochlear implant evaluation was the "60/60" guideline: a hearing loss of 60 decibels or more and a speech understanding score of 60% or less. - Hearing impairment is three times higher among Indigenous children than non-Indigenous children in Australia. - While Australia is considered a world leader in pediatric cochlear implantation, with over 90% of eligible children receiving one, the system for adults has been described as fragmented and inequitable.
